Period Ending | Jun 29, 2012 | Mar 30, 2012 | Dec 30, 2011 | Sep 29, 2011 |
---|
Total Revenue
|
7,179,462
|
6,991,356
|
6,817,508
|
7,277,458
| Cost of Revenue | 6,663,819 | 5,514,379 | 5,242,076 | 4,777,838 | |
Gross Profit
|
515,643
|
1,476,977
|
1,575,432
|
2,499,620
| |
|
Operating Expenses |
|
Research Development |
-
|
-
|
-
|
-
|
|
Selling General and Administrative | (404,414) | 583,048 | 601,697 | 1,545,461 |
|
Non Recurring | 96,548 | 53,015 | 553,962 | 85,688 |
|
Others | 332,501 | 350,152 | 309,168 | 282,263 |
|
|
|
Total Operating Expenses |
-
|
-
|
-
|
-
| | |
Operating Income or Loss
|
491,008
|
490,762
|
110,605
|
586,208
| |
|
Income from Continuing Operations |
|
Total Other Income/Expenses Net | 10,877 | 3,163 | (6,777) | 25,979 |
|
Earnings Before Interest And Taxes | 501,885 | 493,925 | 110,605 | 549,193 |
|
Interest Expense | 2,122 | 5,316 | 10,599 | 14,854 |
|
Income Before Tax | 499,763 | 488,609 | 100,006 | 534,339 |
|
Income Tax Expense | 204,326 | 198,538 | 213,273 | 198,598 |
|
Minority Interest |
-
|
-
|
-
|
-
|
|
|
|
Net Income From Continuing Ops | 295,437 | 290,071 | (113,267) | 335,741 | |
|
Non-recurring Events |
|
Discontinued Operations |
-
|
-
| (661) | 70,373 |
|
Extraordinary Items |
-
|
-
|
-
|
-
|
|
Effect Of Accounting Changes |
-
|
-
|
-
|
-
|
|
Other Items |
-
|
-
|
-
|
-
| | |
Net Income
|
295,437
|
290,071
|
(113,928)
|
406,114
| Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| |
Net Income Applicable To Common Shares
|
295,437
|
290,071
|
(113,928)
|
406,114
|
|